Analystreport

Horizon Therapeutics Public Limited (NASDAQ: HZNP) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $96.00 to $107.00. They now have a

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report